Innovation, design and cutting costs are a huge facet of the pharmaceutical packaging process. The development stage of packaging is an integral component of lowering final production costs and ultimately the rapid production has to be maintained or even surpass drug development in order for the drug itself to launch into commercial phrase without other 'variables' affecting it (such as packaging).
Here at Origin we have a dedicated NPD & Innovation team who work with a range of license holders, pharmaceutical manufacturers (and start ups) CMOs and support their pharmaceutical packaging formation - from 3D printing and modelling of design, manufacturing through to delivering to their drug manufacturing site which is dramatically increasing speed to market and increasing sustainability and saving costs (Hybrid Pharma Packaging Partner).
Origin Pharma Packaging have a packaging design process in place that not only guarantees certification but also drives quality. The four stages that appear throughout the journey of the design, create opportunities to revise what has been delivered so far, to allow the client to make amends to its final outcome (saving on costly amends at the end of the process).
Design & Innovation in Pharmaceutical Packaging by Origin Pharma Packaging
Here at our Pharmaceutical Packaging, Distribution & Innovation Centre we have a dedicated New Product Innovation team. The team have developed the P.I.I.L System (Product, Innovation, Intelligence. Learn System.). We work stringently to adhere to pharmaceutical standard levels, through using our AQSCI model. This ensures and delivers trust to all our clients that engage with us on a new product development project.
In every area of operation, we challenge, what can be done differently? Not just for the sake of doing something different but to give or client added value. We can understand that innovation is critically important but it cannot be at the expense of the four fundamental aspects outlined above.
Our Hybrid Packaging Partner business model allows us to be compete successfully cost/price.
Our outreach across Europe in terms of product and logistics allows us to drive down cost for the client.
Dedicated production cell for project
An agreed buffer stock at manufacturing facility and PPDIC (Pharma Packaging, Distribution and Innovation Centre)
Supply Chain Management of raw material to ensure availability.
Work in with your preferences and MRP, growth plans – difficult to forecast
Flexibility – JIT Delivery or weeks prior to production dependant on client's requirements.
Manufacturing ISO13485 – Storage and distribution ISO15378
Full traceability of all raw materials to source
Only EP grade raw material used
Class 8 clean room production